# Effect on Metabolic Parameters of Abilify in SPR

> **NCT00569764** · — · UNKNOWN · sponsor: **Seoul National Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Schizophrenia
- Metabolic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00569764
- **Lead sponsor:** Seoul National Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-12
- **Primary completion:** —
- **Final completion:** 2009-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569764, "Effect on Metabolic Parameters of Abilify in SPR". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00569764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*